Related Experiment Video
Updated: Aug 14, 2025

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
Published on: August 25, 2022
Fibrinolytic (Thrombolytic) Therapy for Post Intraventricular Hemorrhagic Hydrocephalus in Preterm Infants
1Department of Neurosurgery and Children's Medical Center, Nara Medical University, Kashihara, Japan.
Insights
Fibrinolytic therapy offers a promising treatment for hydrocephalus in preterm infants following intraventricular hemorrhage. This review explores historical methods and introduces a recent urokinase-based approach for improved neurofunctional outcomes.
Area of Science:
- Neonatal intensive care
- Pediatric neurosurgery
- Neurology
Background:
- Intraventricular hemorrhage (IVH) and hydrocephalus are significant challenges in preterm infant care.
- Severe neurological deficits often follow IVH, posing treatment difficulties.
- Improving neurofunctional outcomes in fragile infants is a critical goal.
Purpose of the Study:
- To review the historical development of fibrinolytic therapy for post-IVH hydrocephalus in preterm infants.
- To introduce a contemporary fibrinolytic treatment method utilizing urokinase.
Main Methods:
- Literature review of historical fibrinolytic therapies.
- Description of a recent fibrinolytic treatment protocol using urokinase.
Main Results:
- Fibrinolytic therapy is a viable method for chemically dissolving hematoma.
- Urokinase represents a recent advancement in treating this condition.
Conclusions:
- Fibrinolytic therapy is a promising treatment for post-IVH hydrocephalus in preterm infants.
- Urokinase-based therapy offers a potential strategy for achieving favorable neurofunctional outcomes.
Abstract:
While the survival rate of preterm infants has increased dramatically over the last few decades, intraventricular hemorrhage and subsequent hydrocephalus remain major unsolved problems in neonatal intensive care. Once intraventricular hemorrhage occurs, severe neurological sequelae are inevitable. Treatment of this complicated pathology and achievement of favorable neurofunctional outcomes in fragile infants are crucial challenges for pediatric neurosurgeons. Fibrinolytic therapy, which chemically dissolves hematoma, is a promising and useful treatment method. In this paper, the historical background of fibrinolytic therapy for postintraventricular hemorrhagic hydrocephalus in preterm infants is reviewed and a recent method of fibrinolytic therapy using urokinase is introduced.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins

